Guaianolides from Achillea millefolium L. and their anti-inflammatory activity

Phytochemistry. 2023 Jun:210:113647. doi: 10.1016/j.phytochem.2023.113647. Epub 2023 Mar 23.

Abstract

Seven previously undescribed guaianolides, millefolactons A-G, and three known analogues, millefoliumins A-C, were isolated from the whole plant of Achillea millefolium L. growing in Xinjiang, China. Their structures were elucidated using the HR-ESI-MS and NMR data analyses. The absolute configurations of millefolactons A-G were determined by single-crystal X-ray crystallography, ECD data analysis, and quantum-chemical ECD calculations. Millefolactons A-E are rare 3-oxa-guaianolides. Millefolacton C, millefolacton E, millefoliumin A and millefoliumin B exhibited enzymatic inhibition of 15-LOX. Molecular docking simulations were conducted to visualize interactions between the four active compounds and 15-LOX and determine binding mechanisms. Moreover, a LPS-induced BV2 cell model was used to further investigate the anti-inflammatory mechanism of millefolacton C. As a result, millefolacton C significantly inhibited NO release, repressed levels of pro-inflammatory cytokines including TNF-α, IL-18, PGE2 and IL-6, and inhibited the protein expression of iNOS and COX2 proteins. In addition, millefolacton C could potently decreased the expression of NLRP3, ASC, and IL-1β proteins in LPS-stimulated BV2 cells. These results indicate that the 3-oxa-guaianolides from A. millefolium L. offer great potential as leads for anti-inflammatory drug development.

Keywords: 15-LOX inhibitors; 3-oxa-guaianolides; Achillea millefolium L.; Anti-inflammatory activity; Asteraceae; Millefolactons A–G; Molecular docking.

MeSH terms

  • Achillea*
  • Anti-Inflammatory Agents / pharmacology
  • Lipopolysaccharides / pharmacology
  • Molecular Docking Simulation
  • Plant Extracts / pharmacology

Substances

  • Lipopolysaccharides
  • Plant Extracts
  • Anti-Inflammatory Agents